Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination.
The Development of Prophylactic and Therapeutic EBV Vaccines.
Frequent laboratory abnormalities in CIDP patients.
Comparing Three Dual-Task Methods and the Relationship to Physical and Cognitive Impairment in People with Multiple Sclerosis and Controls.
Relapses in multiple sclerosis: effects of high-dose steroids on cortical excitability.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
An adult case of multiphasic disseminated encephalomyelitis manifesting with optic neuritis.
The potential of epigenetic therapies in neurodegenerative diseases.
Multiple sclerosis for nurse practitioners.
Vitamin d3 concentration correlates with the severity of multiple sclerosis.
PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica.
White and Gray Matter Volume Changes and Correlation with Visual Evoked Potential in Patients with Optic Neuritis: A Voxel-Based Morphometry Study.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study.
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Vaccination, infection, and the risk for multiple sclerosis.
Myelination, oligodendrocytes, and serious mental illness.
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NO.
In Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous System.
Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
534
535
536
537
538
539
540
541
542
…
next ›
last »